V

Vical Incorporated

209 employees

Vical develops biopharmaceutical drugs to prevent and treat chronic or life-threatening infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Invasive fungal infection
Biopharma
DNA delivery technologies
Health Care
Invasive aspergillosis
Herpes
Antifungal
Genital herpes
Hepatitis B
Infectious diseases
infectious disease vaccines
HBV
Genetics
Medical
HSV-2

Date founded

1987

Funding rounds raised

V

Vical Incorporated raised undisclosed on January 1, 1992

Investors: Venrock

V

Vical Incorporated raised undisclosed on September 29, 1988

Investors: Hilman Ventures and Morgenthaler

FAQ